Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften E-learning Web-tv Video Audio
Tips voor Mijn BSL
UITGEBREID ZOEKEN
Inloggen
Top
Quality of Life Research
Gepubliceerd in: Quality of Life Research 2/2010

01-03-2010 | Brief Communication

Reliability and validity of the Greek translation of the MOS-HIV health survey in HIV-infected individuals

Auteurs: Panagiota G. Stasinopoulou, Chara Tzavara, Christine Dimitrakaki, Ourania Georgiou, Ioannis G. Baraboutis, Athanasios Skoutelis, Vassilios Papastamipoulos, Yannis Tountas

Gepubliceerd in: Quality of Life Research | Uitgave 2/2010

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

Objectives

This study was intended to present evidence for the reliability and validity of a Greek translation of the Medical Outcomes Study-HIV Health Survey (MOS-HIV). Design: Sample consisted of 154 HIV-positive men and women, regardless of disease stage, who are being followed at the department of Infectious Diseases of a tertiary hospital of Athens, Greece.

Methods

The translated Greek version of the MOS-HIV instrument, a brief, comprehensive 35-item health-related quality of life questionnaire, was used to assess ten dimensions of health including overall quality of life, pain, physical functioning, role functioning, social functioning, mental health, energy/fatigue, cognitive function, health distress, and health transition. Additional socio-demographic data and clinical parameters were also collected. Standard guidelines were followed for questionnaire translation to the Greek language. Internal consistency reliability using Cronbach’s alpha and the range of measurement of the MOS-HIV subscales were examined. Convergent validity was further examined with the intercorrelations of subscales. ROC analysis was used to estimate the ability of the subscales to discriminate patients according to the characteristics of the disease [i.e. asymptomatic, symptomatic and AIDS, CD4+ lymphocyte count (<200 cells/mm3 and >200 cells/mm3)] and assess concurrent validity.

Results

All the MOS-HIV scales exceeded the minimum reliability standard of 0.70. Physical functioning and health distress had the greatest reliability coefficient, equal to 0.87 and 0.88, respectively. Correlations among MOS-HIV scales were all significant. Physical functioning, pain, and physical health summary scales were significantly lower for AIDS patients compared to asymptomatic HIV+ individuals. All scales except for role functioning and health transition could discriminate well subjects with CD4+ lymphocyte count <200 cells/mm3 and >200 cells/mm3.

Conclusions

The Greek version of the MOS-HIV had good reliability and validity among patients with AIDS. Convergent and concurrent validity were generally confirmed. The MOS-HIV may be useful in assessing health-related quality of life in AIDS patients in Greece. Further research is needed for the evaluation of the Greek version of the MOS-HIV responsiveness to changes over time.
vorige artikel Health-related quality of life among paediatric survivors of primary brain tumours and acute leukaemia
volgende artikel Psychometric evaluation of the impact of cancer (IOC-CS) scale for young adult survivors of childhood cancer
Literatuur
1.
Krentz, H. B., & Gill, M. J. (2003). The impact on health related quality of life of treatment interruptions in HIV-1 infected patients. AIDS, 17, 631–633.CrossRefPubMed
2.
Wu, A. W. (2000). Quality of life assessment comes of age in the era of highly active antiretroviral therapy. AIDS, 14(10), 1449–1451.CrossRefPubMed
3.
Ruiz Perez, I., et al. (2005). Health-related quality of life of patients with HIV: Impact of sociodemographic, clinical and psychosocial factors. Quality of Life Research, 14, 1301–1310.CrossRefPubMed
4.
Henry, K. (2000). The case for more cautious, patient focused antiretroviral therapy. Annals of Internal Medicine, 132, 306–311.PubMed
5.
Shumaker, S. A., Ellis, S., & Naughton, M. (1997). Assessing health-related quality of life in HIV disease: Key measurement issues. Quality of Life Research, 6, 475–480.CrossRefPubMed
6.
Skevington, S. M., & O’Connell, K. A. (2003). Measuring quality of life in HIV and AIDS: A review of the recent literature. Psychology & Health, 18(3), 331–350.CrossRef
7.
Wu, A. W., Rubin, H. R., Mathews, W. C., et al. (1991). A health status questionnaire using 30 items from the Medical Outcomes Study: Preliminary validation in persons with early HIV infection. Medical Care, 29, 786–798.CrossRefPubMed
8.
Wu, A. W., Revicki, D. A., Jacobson, D., et al. (1997). Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV). Quality of Life Research, 6, 481–493.CrossRefPubMed
9.
Wu, A. W., Hays, R. D., Kelly, S., et al. (1997). Applications of the Medical Outcomes Study health-related quality of life measures in HIV/AIDS. Quality of Life Research, 6(6), 531–554.CrossRefPubMed
10.
Revicki, D. A., Sorensen, S., & Wu, A. W. (1998). Reliability and validity of physical health and Mental Health summary scores from the MOS HIV Health Survey. Medical Care, 36(2), 126–137.CrossRefPubMed
11.
Nieuwerk, P. T., Gisolf, E. H., Colebunders, R., Wu, A. W., Danner, S. A., & Sprangers, M. A. (2000). Quality of life in asymptomatic and symptomatic HIV-infected patients in a trial of ritonavir/saquinavir therapy. The Prometheus Study Group. AIDS, 14(2), 181–187.CrossRef
12.
Revicki, D. A., Moyle, G., Stellbrink, H. J., & Barker, C. (1999). Quality of Life outcomes of combination zalcitabine-zidovudine, saquinavir-zidovudine and saquinavir-zalcitabine-zidovudine therapy for HIV-infected adults with CD4 cell counts between 50 and 350 per cubic millimetre. PISCES(SV14604) Study Group. AIDS, 13(7), 851–858.CrossRefPubMed
13.
Weinfurt, K. P., Willke, R. J., Glick, H. A., Fremuth, W. W., & Schulman, K. A. (2000). Relationship between CD4 count, viral burden and quality of life over time in HIV-1 infected patients. Medical Care, 38(4), 404–410.CrossRefPubMed
14.
Scott-Lennox, J. A., Wu, A. W., Boyer, J., et al. (1999). Reliability and validity of French, German, Italian, Dutch, and UK English translations of the medical outcomes study HIV health survey. Medical Care, 37(9), 908–925.CrossRefPubMed
15.
Schifano, P., Borgia, P., Wu, A. W., et al. (2003). Validity and reliability of the Italian translation of the MOS-HIV health survey in persons with AIDS. Quality of Life Research, 12, 1137–1146.CrossRefPubMed
16.
Murri, R., Ammasari, A., Fantoni, M., et al. (1997). Disease-related factors associated with health-related quality of life in people with non-advanced HIV disease assessed using an Italian version of the MOS-HIV health survey. Journal of Acquired Immune Deficiency Syndromes and Human Retroviruses, 16(5), 350–356.
17.
Badia, X., Podzamczer, D., Garcia, M., Lopez-Lavid, C. C., Consigliore, E., & The Spanish MOS-HIV and MQOL-HIV Validation Group. (1999). A randomised study comparing instruments for measuring health related quality of life in HIV-infected patients. AIDS, 13, 1727–1735.CrossRefPubMed
18.
Kohli, R. M., Sane, S., Kumar, K., et al. (2005). Modification of medical outcome study (MOS) instrument for quality of life assessment & its validation in HIV infected individuals in India. The Indian Journal of Medical Research, 122, 297–304.PubMed
19.
Paton, N. I., Chapman, C. A., Chan, S. P., Karen, M. T., Tan, K. M., Leo, Y. S., et al. (2002). Validation of the medical outcome study HIV (1), health survey as a measure of quality of life in HIV infected patients in Singapore. International Journal of STD and AIDS, 13, 456–461.CrossRefPubMed
20.
Bullinger, M., Alonso, J., Apolone, G., et al. (1998). Translating health status questionnaires and evaluating their quality: The IQOLA Project approach. Journal of Clinical Epidemiology, 51, 913–923.CrossRefPubMed
21.
Guyatt, G. H. (1995). The philosophy of health-related quality of life translation. In S. A. Shumaker & R. A. Berzon (Eds.), The international assessment of health-related quality of life (pp. 139–143). Oxford, New York: Rapid Communications.
22.
Bullinger, M., Anderson, R., Cella, D., & Aaronson, N. (1995). Developing and evaluating cross-cultural instruments from minimum requirements to optimal models. In S. A. Shumaker & R. A. Berzon (Eds.), The international assessment of health-related quality of life (pp. 83–91). Oxford, New York: Rapid Communications.
23.
Herdman, M., Fox-Rushby, J., & Badia, X. (1997). “Equivalence” and the translation and adaptation of health-related quality of life questionnaires. Quality of Life Research, 6, 237–247.CrossRefPubMed
24.
Acquadro, C., Conway, K., Giroudet, C., et al. (2004). Linguistic validation manual for patient-reported outcomes (PRO) instruments (pp. 40–58). Lyon: Mapi Research Institute.
25.
Lohr, K. N. (2002). Assessing health status and quality-of-life instruments: Attributes and review criteria Journal. Quality of Life Research, 11(3), 193–205.CrossRef
26.
Burgess, A., Dayer, M., Catalan, J., et al. (1993). The reliability and validity of two HIV-specific health-related quality of life measures: A preliminary analysis. AIDS, 7, 1001–1008.CrossRefPubMed
27.
Ganz, P. A., Schag, C. A., Kahn, B., & Petersen, L. (1994). Assessing the quality of life of HIV infected persons: Clinical and descriptive information from studies with the HOPES. Psychology & Health, 9, 93–110.CrossRef
28.
Copfer, A. E., Ampel, N. M., Hughes, T. E., et al. (1996). The use of two measures of health-related quality of life in HIV-infected individuals: A cross-sectional comparison. Quality of Life Research, 5, 281–286.CrossRefPubMed
29.
Mocroft, A., Johmson, M., Sabin, C., et al. (1995). Staging system for clinical AIDS patients. Lancet, 346, 12–17.CrossRefPubMed
30.
Holmes, W. C., & Shea, J. A. (1999). Two approaches to measuring quality of life in the HIV/AIDS population: HAT-QOL and MOS-HIV. Quality of Life Research, 8(6), 515–527.CrossRefPubMed
31.
Revicki, D. A., Wu, A. W., & Brown, R. (1995). Change in clinical status, health status and health 57 utility outcomes in HIV-infected patients. Medical Care, 33(4), AS173–AS182.PubMed
32.
Campsmith, M. L., Nakashima, A. K., & Davidson, A. J. (2003). Self-reported health related quality of life in persons with HIV infection: Results from multi-sites interview project. Health and Quality of Life Outcomes, 1, 12.CrossRefPubMed
33.
Smith, M. Y., Feldmen, J., Kelly, P., Dehovitz, J. A., Chirgwin, K., & Minkoff, H. (1996). Health related quality of life of HIV infected women: Evidence for the reliability, validity and responsiveness of the medical outcomes study short form 20. Quality of Life Research, 5, 47–55.CrossRefPubMed
Metagegevens
Titel
Reliability and validity of the Greek translation of the MOS-HIV health survey in HIV-infected individuals
Auteurs
Panagiota G. Stasinopoulou
Chara Tzavara
Christine Dimitrakaki
Ourania Georgiou
Ioannis G. Baraboutis
Athanasios Skoutelis
Vassilios Papastamipoulos
Yannis Tountas
Publicatiedatum
01-03-2010
Uitgeverij
Springer Netherlands
Gepubliceerd in
Quality of Life Research / Uitgave 2/2010
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-009-9573-0

Andere artikelen Uitgave 2/2010

Quality of Life Research 2/2010 Naar de uitgave

OriginalPaper

Validity of information obtained from a method for estimating cancer costs from the perspective of patients and caregivers

OriginalPaper

Communicating about the experience of pain and fatigue in disability

ReviewPaper

Somatically ill persons’ self-nominated quality of life domains: review of the literature and guidelines for future studies

Brief Communication

Factorial structure and validity of the Multicultural Quality of Life Index

Brief Communication

Cross-national comparability of the WHOQOL-BREF: A measurement invariance approach

OriginalPaper

The effect of body mass on health-related quality of life among Singaporean adolescents: results from the SCORM study